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Abstract Screening asymptomatic subjects to streamline
measures for the prevention of cardiovascular events
remains a major challenge. The established primary pre-
vention risk-scoring methods use equations derived from
large prospective cohort studies, but further fine-tuning of
cardiovascular risk assessment remains important as 25 %
of individuals with low estimated risk may experience
cardiac events. Independent studies provided evidence that
extended risk assessment using coronary artery calcium
quantification may improve risk stratification as it can lead
to reclassification of persons at increased risk. Particularly
in intermediate-risk subjects, coronary artery calcium
scoring can help to correctly identify individuals at highest
risk. Data on the extent of calcification of the ascending
and descending thoracic aorta might be useful for addi-
tional cardiovascular risk stratification. Future analyses and
studies will be required to answer the question of whether
the implementation of such data may allow further fine-
tuning of cardiovascular risk prediction in specific sub-
populations—for instance in women or men with an
increased risk of stroke and/or symptomatic peripheral
vascular disease.
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Cardiovascular events are important causes of death and
disability. Primary prevention to lower the incidence of
such events is of paramount importance. Nevertheless,
screening asymptomatic subjects to streamline preventive
measures remains a major challenge [1]. Classical cardio-
vascular risk factors such as age, gender, cholesterol levels,
blood pressure, and smoking are traditionally employed to
assess the individual risk status, to trigger lifestyle modi-
fication, and to guide drug prescription in order to prevent
cardiovascular events. Ideally, a predictor of the overall
risk of cardiovascular events should be based on a robust
multifactorial model [2–5]. The established primary pre-
vention risk-scoring methods use equations derived from
large prospective cohort studies, such as the European
Systematic Coronary Risk Evaluation Project (SCORE)
[2], the German Prospective Cardiovascular Mu¨nster
(PROCAM) study [3], and the US-American Framingham
Heart and Offspring Studies [4, 5]. These estimated risk
values even appear to be related to coronary plaque pro-
gression rates [7]. Risk prediction models may be most
favorable for the continent, subcontinent, or even country,
from which an underlying data set is derived, which is the
reason for the current coexistence of several cardiovascular
risk scores [2–5]. Current guidelines on dislipidemia use
the estimated individual risk from such scoring systems to
guide lipid-lowering therapy with statins in primary car-
diovascular prevention [6]. The abovementioned facts
underline the importance of prospective cohort studies to
gain information about population-based cardiovascular
event risks, which is required to develop evidence-based
clinical guidelines that have major impact on our daily
clinical practice.
Fine-tuning of cardiovascular risk assessment remains
important as 25 % of individuals with low estimated risk
may experience cardiac events [1]. Independent studies
M. Hartmann  C. von Birgelen (&)
Department of Cardiology, Thoraxcentrum Twente,
Medisch Spectrum Twente, Haaksbergerstraat 55,
7513 ER Enschede, The Netherlands
e-mail: c.vonbirgelen@mst.nl
C. von Birgelen
MIRA Institute, University of Twente, Enschede,
The Netherlands
123
Int J Cardiovasc Imaging
DOI 10.1007/s10554-012-0055-z
provided evidence that extended risk assessment using
coronary artery calcium (CAC) quantification may improve
risk stratification as it can lead to reclassification of persons
at increased risk [8–12]. One example of such large,
population-based cohort studies is the Heinz Nixdorf Recall
Study (4814 participants from the Ruhr metropolitan area in
Germany), which investigates the ability of subclinical
CAC quantification with electron-beam computed tomog-
raphy scanning to predict the risk of major cardiovascular
events at five-year follow-up above and beyond traditional
cardiovascular risk factors [1, 11, 13]. This study demon-
strated that a higher cardiovascular risk burden was asso-
ciated with higher CAC scores and that CAC scoring
improved risk stratification, discrimination, and reclassifi-
cation [1, 11]. Particularly in intermediate-risk subjects,
CAC scoring can help to correctly identify individuals at
highest risk, which might contribute to reducing the number
of coronary events in the general population [1, 11]. A
representative US-American population, the Multi-Ethnic
Study of Atherosclerosis (MESNA), also demonstrated an
incremental prognostic value of absolute CAC scores over
several traditional cardiovascular risk factors [14].
In the current issue of the journal, Raimund Erbel and
his coworkers present interesting thoracic aortic calcifica-
tion (TAC) data derived from the Heinz Nixdorf Recall
cohort study [15]. The extent of calcification of the
ascending and descending thoracic aorta, as determined
with electron-beam computed tomography, was signifi-
cantly associated with CAC burden [15]. While TAC lar-
gely shared cardiovascular risk factors with coronary artery
disease, TAC was independently related to CAC [15].
In fact, these data from a general population in Western
Europe [15] are very welcome. Data on TAC in large,
general populations are scarce and were previously merely
available from US-American populations [16–19]. Wong
et al. studied in 2303 asymptomatic participants the ability
of CAC and TAC to predict coronary heart disease and
cardiovascular events and found that CAC, but not TAC,
showed a strong relation with coronary heart disease and
cardiovascular events [16]. However, in another US-
American study, the MESNA study (n = 6814 of four
ethnic groups), TAC was found to be a strong predictor of
CAC independent of cardiovascular risk factors [17, 18].
Santos et al. even demonstrated in a cohort of 8401
asymptomatic, predominantly white US-Americans,
undergoing cardiac risk factor evaluation and scanning
with electron-beam computed tomography, that the pres-
ence of TAC was associated with all-cause mortality, a
relation that was independent of conventional cardiovas-
cular risk factors and the presence of CAC [19]. In a Dutch
high-risk population of 958 heavy smokers, Jacobs et al.
found that CAC was a stronger predictor of cardiovascular
events than TAC [20]. However, in this quite specific
subpopulation of a lung cancer screening trial, TAC was
stronger associated with vascular disease and events such
as stroke as well as the occurrence of aortic aneurysms and
occlusive peripheral arterial disease [20].
The present report from the Heinz Nixdorf Recall Study
provides valuable computed age and gender-specific per-
centile curves for TAC in a Western European general
population [15]. These percentiles may help to interpret
individual thoracic calcification values and might be useful
for additional cardiovascular risk stratification. Future
analyses and studies will be required to answer the question
of whether the implementation of these data may allow
further fine-tuning of cardiovascular risk prediction in
specific subpopulations—for instance in women or men
with an increased risk of stroke and/or symptomatic
peripheral vascular disease.
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